These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 1571752

  • 1. Moclobemide versus clomipramine in endogenous depression. A double-blind randomised clinical trial.
    Guelfi JD, Payan C, Fermanian J, Pedarriosse AM, Manfredi R.
    Br J Psychiatry; 1992 Apr; 160():519-24. PubMed ID: 1571752
    [Abstract] [Full Text] [Related]

  • 2. Moclobemide and clomipramine in endogenous depression. A randomized clinical trial.
    Koczkas C, Holm P, Karlsson A, Nagy A, Ose E, Pétursson H, Ulverås L, Wenedikter O.
    Acta Psychiatr Scand; 1989 Jun; 79(6):523-9. PubMed ID: 2669440
    [Abstract] [Full Text] [Related]

  • 3. Moclobemide versus clomipramine in the treatment of depression: a double-blind multicentre study in Belgium.
    Dierick M, Cattiez P, Franck G, Burton P, Defleur J, Hermans W, Roelandts A, Wolfrum C, Berger M, Hellstern K.
    Acta Psychiatr Scand Suppl; 1990 Jun; 360():50-1. PubMed ID: 2248071
    [Abstract] [Full Text] [Related]

  • 4. Moclobemide versus clomipramine in the treatment of depression: a multicentre trial in Spain.
    Civeira J, Cervera S, Giner J, Allen SR, Hellstern K, Malanowski H, Wirz R, Klar K.
    Acta Psychiatr Scand Suppl; 1990 Jun; 360():48-9. PubMed ID: 2248070
    [Abstract] [Full Text] [Related]

  • 5. Moclobemide versus clomipramine in the treatment of depression: a single-centre study, Federal Republic of Germany.
    Funke HJ, Moritz E, Hellstern K, Malanowski H.
    Acta Psychiatr Scand Suppl; 1990 Jun; 360():46-7. PubMed ID: 2248069
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Moclobemide versus clomipramine in nonmelancholic, nonpsychotic major depression. A Study group.
    Lecrubier Y, Pedarriosse AM, Payan C, Schmid-Burgk W, Stabl M.
    Acta Psychiatr Scand; 1995 Oct; 92(4):260-5. PubMed ID: 8848950
    [Abstract] [Full Text] [Related]

  • 10. Multicenter double-blind study of moclobemide and maprotiline.
    Vaz-Serra A, Figueira ML, Firmino H, Albuquerque AJ, Jara JM, Pestana LC.
    Clin Neuropharmacol; 1994 Oct; 17 Suppl 1():S38-49. PubMed ID: 7954483
    [Abstract] [Full Text] [Related]

  • 11. Moclobemide: a reversible MAO-A-inhibitor showing weaker antidepressant effect than clomipramine in a controlled multicenter study. Danish University Antidepressant Group.
    J Affect Disord; 1993 Jun; 28(2):105-16. PubMed ID: 8354766
    [Abstract] [Full Text] [Related]

  • 12. Moclobemide and clomipramine in the treatment of depression. A randomized clinical trial.
    Larsen JK, Holm P, Mikkelsen PL.
    Acta Psychiatr Scand; 1984 Sep; 70(3):254-60. PubMed ID: 6388247
    [Abstract] [Full Text] [Related]

  • 13. Dimensional assessment of onset of action of antidepressants: a comparative study of moclobemide vs. clomipramine in depressed patients with blunted affect and psychomotor retardation.
    Jouvent R, Le Houezec J, Payan C, Mikkelsen H, Fermanian J, Millet V, Dufour H.
    Psychiatry Res; 1998 Jul 13; 79(3):267-75. PubMed ID: 9704873
    [Abstract] [Full Text] [Related]

  • 14. A double-blind comparison of moclobemide and thioridazine versus moclobemide and placebo in the treatment of refractory, severe depression.
    Stabl M, Kasas A, Blajev B, Bajetta G, Zöchling R, Holsboer-Trachsler E, Realini R, Schäublin-Loidl M.
    J Clin Psychopharmacol; 1995 Aug 13; 15(4 Suppl 2):41S-45S. PubMed ID: 7593730
    [Abstract] [Full Text] [Related]

  • 15. Moclobemide versus fluoxetine for double depression: a randomized double-blind study.
    Duarte A, Mikkelsen H, Delini-Stula A.
    J Psychiatr Res; 1996 Aug 13; 30(6):453-8. PubMed ID: 9023788
    [Abstract] [Full Text] [Related]

  • 16. Moclobemide and placebo in mild major depression: a double-blind randomized trial.
    Ose E, Holm P.
    Psychopharmacology (Berl); 1992 Aug 13; 106 Suppl():S114-5. PubMed ID: 1546122
    [Abstract] [Full Text] [Related]

  • 17. Moclobemide versus fluoxetine for major depressive episodes.
    Geerts S, Bruynooghe F, De Cuyper H, Demeulemeester F, Haazen L.
    Clin Neuropharmacol; 1994 Aug 13; 17 Suppl 1():S50-7. PubMed ID: 7954484
    [Abstract] [Full Text] [Related]

  • 18. A double blind trial of moclobemide versus amitriptyline in the treatment of depressive disorders.
    Newburn GM, Fraser AR, Menkes DB, Mullen PE.
    Aust N Z J Psychiatry; 1990 Dec 13; 24(4):475-9. PubMed ID: 2073222
    [Abstract] [Full Text] [Related]

  • 19. Moclobemide versus tranylcypromine in the treatment of depression.
    Rossel L, Moll E.
    Acta Psychiatr Scand Suppl; 1990 Dec 13; 360():61-2. PubMed ID: 2248075
    [Abstract] [Full Text] [Related]

  • 20. The Major Depression Rating Scale (MDS). Inter-rater reliability and validity across different settings in randomized moclobemide trials. Danish University Antidepressant Group.
    Bech P, Stage KB, Nair NP, Larsen JK, Kragh-Sørensen P, Gjerris A.
    J Affect Disord; 1997 Jan 13; 42(1):39-48. PubMed ID: 9089057
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.